A detailed history of Roof Eidam & Maycock transactions in Eli Lilly & CO stock. As of the latest transaction made, Roof Eidam & Maycock holds 1,070 shares of LLY stock, worth $953,444. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,070
Previous 1,070 -0.0%
Holding current value
$953,444
Previous $832,000 16.35%
% of portfolio
0.26%
Previous 0.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $138,266 - $161,108
-430 Reduced 28.67%
1,070 $391,000
Q1 2020

May 11, 2020

BUY
$119.05 - $147.35 $178,575 - $221,025
1,500 New
1,500 $208,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $847B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Roof Eidam & Maycock Portfolio

Follow Roof Eidam & Maycock and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roof Eidam & Maycock, based on Form 13F filings with the SEC.

News

Stay updated on Roof Eidam & Maycock with notifications on news.